What Is Mazdutide?
Buy Mazdutide
Mazdutide is a once-weekly injectable medication developed to aid in weight management and improve blood sugar control in people with type 2 diabetes.
It has been approved in China under the brand name Xinermei, produced by Innovent Biologics. Internationally, the drug is being co-developed with Eli Lilly, which is conducting broader global clinical trials to evaluate its effectiveness across diverse populations.
Unlike medications such as Wegovy (semaglutide), mazdutide is a dual-agonist peptide. This means it activates two key hormone pathways:
-
GLP-1, which helps regulate appetite and blood sugar levels
-
Glucagon, which plays a role in fat metabolism and energy expenditure
By stimulating both pathways, mazdutide is designed to potentially deliver greater weight loss effects compared to treatments that target GLP-1 alone.
Beyond obesity and type 2 diabetes, mazdutide is also under investigation for several other conditions, including metabolic-associated fatty liver disease (MAFLD), obstructive sleep apnoea, alcohol use disorder, heart failure, and adolescent obesity.
How Does Mazdutide Work?
Mazdutide works in a way similar to Wegovy and Mounjaro, but it targets a different hormonal combination. By activating both GLP-1 and glucagon receptors, it helps reduce appetite, improve glucose control, and enhance energy use, contributing to weight reduction and metabolic improvements.
1 vial x 10 mg





Reviews
There are no reviews yet.